Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Clemons

Showing results (1-10 of 267) with videos related to

Pageof 27
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 21, 2018
Guidelines versus individualized care for the management of CINVMark Clemons
Breast Cancer Research and Treatment|October 25, 2006
Identifying menopause in breast cancer patients: considerations and implicationsMark Clemons, Christine Simmons
Seminars in Oncology|October 19, 2004
Perspectives on the future of bisphosphonate use in breast cancer patientsMark Clemons, Daniel Rea
Cancer Treatment Reviews|March 7, 2006
Trastuzumab after primary treatment for early stage HER2-positive breast cancer reduces recurrenceRebecca Dent, Mark Clemons
Breast Cancer Research and Treatment|April 15, 2005
Should oral bisphosphonates be standard of care in women with early breast cancer?Mark Clemons, Sunil Verma
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 13, 2006
End-of-life care in CanadaChristine Simmons, Mark Clemons
The Oncologist|August 4, 2007
First-line treatment options for patients with HER-2 negative metastatic breast cancer: the impact of modern adjuvant chemotherapySunil Verma, Mark Clemons
BMJ (Clinical Research Ed.)|November 5, 2005
Adjuvant trastuzumab for breast cancerRebecca Dent, Mark Clemons
Canadian Family Physician Medecin De Famille Canadien|August 9, 2006
Helping expectations become reality for dying cancer patientsChristine Simmons, Mark Clemons
Thrombosis Research|June 9, 2018
Poor outcomes after venous thromboembolism in cancer patients: It's time to change practiceAurélien Delluc, Mark Clemons
Pageof 27

Showing results (1-10 of 267) with videos related to

Sort By:
Pageof 27
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 21, 2018
Guidelines versus individualized care for the management of CINVMark Clemons
Breast Cancer Research and Treatment|October 25, 2006
Identifying menopause in breast cancer patients: considerations and implicationsMark Clemons, Christine Simmons
Seminars in Oncology|October 19, 2004
Perspectives on the future of bisphosphonate use in breast cancer patientsMark Clemons, Daniel Rea
Cancer Treatment Reviews|March 7, 2006
Trastuzumab after primary treatment for early stage HER2-positive breast cancer reduces recurrenceRebecca Dent, Mark Clemons
Breast Cancer Research and Treatment|April 15, 2005
Should oral bisphosphonates be standard of care in women with early breast cancer?Mark Clemons, Sunil Verma
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 13, 2006
End-of-life care in CanadaChristine Simmons, Mark Clemons
The Oncologist|August 4, 2007
First-line treatment options for patients with HER-2 negative metastatic breast cancer: the impact of modern adjuvant chemotherapySunil Verma, Mark Clemons
BMJ (Clinical Research Ed.)|November 5, 2005
Adjuvant trastuzumab for breast cancerRebecca Dent, Mark Clemons
Canadian Family Physician Medecin De Famille Canadien|August 9, 2006
Helping expectations become reality for dying cancer patientsChristine Simmons, Mark Clemons
Thrombosis Research|June 9, 2018
Poor outcomes after venous thromboembolism in cancer patients: It's time to change practiceAurélien Delluc, Mark Clemons
Pageof 27